|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Dr. Joanna Horobin Joins Verastem, Inc. (VSTM) as Chief Medical Officer
10/23/2012 9:01:38 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the appointment of Joanna Horobin, M.B., Ch.B., as Chief Medical Officer. Dr. Horobin was most recently the President of Syndax Pharmaceuticals, Inc. and has been responsible for the development and approval of multiple drugs over the course of her career. “Joanna’s track record of execution across a broad range of products positions us well as we progress towards initiating a potential registration study of VS-6063 in mesothelioma mid-next year,” said Christoph Westphal, M.D., Ph.D., Chairman and CEO of Verastem.
|
|
|
|
|
|
|
|
|
|
|